{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:00:21Z","timestamp":1788926421826,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s43441-022-00378-0","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T15:02:46Z","timestamp":1644591766000},"page":"382-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions"],"prefix":"10.1007","volume":"56","author":[{"given":"Andreea","family":"Molnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Berges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond B.","family":"Masa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"DeMets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis G.","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"378_CR1","unstructured":"United States Food and Drug Administration. Why you should not use Ivermectin to treat or prevent COVID-19 patients. https:\/\/www.fda.gov\/consumers\/consumer-updates\/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19. Published March 5, 2021. Accessed November 22, 2021."},{"issue":"9","key":"378_CR2","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1007\/s11606-021-06948-6","volume":"36","author":"JN Lind","year":"2021","unstructured":"Lind JN, Lovegrove MC, Geller AI, Uyeki TM, Datta SD, Budnitz DS. Increase in outpatient ivermectin dispensing in the us during the covid-19 pandemic: a cross-sectional analysis. J Gen Intern Med. 2021;36(9):2909\u201311. https:\/\/doi.org\/10.1007\/s11606-021-06948-6.","journal-title":"J Gen Intern Med"},{"key":"378_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-021-00430-5","author":"AK Zaidi","year":"2021","unstructured":"Zaidi AK, Dehgani-Mobaraki P. The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review. J Antibiot (Tokyo). 2021. https:\/\/doi.org\/10.1038\/s41429-021-00430-5.","journal-title":"J Antibiot (Tokyo)"},{"key":"378_CR4","unstructured":"National Institutes of Health COVID treatment guidelines: Ivermectin Updated February 21, 2021. https:\/\/www.covid19treatmentguidelines.nih.gov\/therapies\/antiviral-therapy\/ivermectin\/. Accessed November 22, 2021."},{"key":"378_CR5","unstructured":"National Institutes of Health. Prevention and Prophylaxis of SARS-CoV-2 Infection. https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/prevention-of-sars-cov-2\/. Last updated July 8, 2021."},{"key":"378_CR6","unstructured":"World Health Organization. WHO advises that Ivermectin only be used to treat COVID-19 within clinical trials. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials. Published March 21, 2021. Accessed November 22, 2021."},{"key":"378_CR7","unstructured":"European Medicines Agency. EMA advises against use of ivermectin in treatment or prevention of COVID-19 outside randomized clinical trials. https:\/\/www.ema.europa.eu\/en\/news\/ema-advises-against-use-ivermectin-prevention-treatment-covid-19-outside-randomised-clinical-trials. Last updated March 22, 2021. Accessed November 22, 2021."},{"issue":"5","key":"378_CR8","doi-asserted-by":"publisher","first-page":"030006052110135","DOI":"10.1177\/03000605211013550","volume":"49","author":"R Mahmud","year":"2021","unstructured":"Mahmud R, Rahman M, Alam I, et al. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J Int Med Res. 2021;49(5):030006052110135. https:\/\/doi.org\/10.1177\/03000605211013550.","journal-title":"J Int Med Res"},{"issue":"14","key":"378_CR9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/jama.2021.3071","volume":"325","author":"E Lopez-Medina","year":"2021","unstructured":"Lopez-Medina E, Lopez P, Hurtado IC, et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19 - A randomized clinical trial. JAMA. 2021;325(14):1426\u201335. https:\/\/doi.org\/10.1001\/jama.2021.3071.","journal-title":"JAMA"},{"key":"378_CR10","unstructured":"Hamel L, Kirzinger A, Mu\u00f1ana C, et al. KFF COVID-19 Vaccine Monitor December 2020. Kaiser Family Foundation. https:\/\/www.kff.org\/coronavirus-covid-19\/report\/kff-covid-19-vaccine-monitor-december-2020\/. Published December 15, 2020. Accessed November 22, 2021"},{"key":"378_CR11","unstructured":"US FDA Bulletin. Know your treatment options for COVID-19. https:\/\/www.fda.gov\/consumers\/consumer-updates\/know-your-treatment-options-covid-19. Published July 30, 2021. Accessed November 22, 2021."},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.amjmed.2021.06.030","volume":"134","author":"DG Maki","year":"2021","unstructured":"Maki DG, Hennekens CH. Health Care Workers Need COVID-19 Vaccination: Clinical, Public Health, and Ethical Considerations. Am J Med. 2021;134:1437\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2021.06.030.","journal-title":"Am J Med"},{"issue":"7","key":"378_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.37765\/ajmc.2021.88670","volume":"27","author":"DG Maki","year":"2021","unstructured":"Maki DG, Solano ASM, et al. Control of COVID-19 in the US The case for masking. Am J Manag Care. 2021;27(7):218\u201320. https:\/\/doi.org\/10.37765\/ajmc.2021.88670.","journal-title":"Am J Manag Care"},{"key":"378_CR14","unstructured":"Tracking. Johns Hopkins University Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/data. Accessed November 22, 2021."},{"key":"378_CR15","unstructured":"BBC News COVID-19 in Australia: Brisbane lockdown after Delta variant. https:\/\/www.bbc.com\/news\/world-australia-58039299. Published July 31, 2021. Accessed November 22, 2021."},{"key":"378_CR16","unstructured":"Centers for Disease Control and Prevention. COVID data tracker: variant proportions. https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions. Accessed November 22, 2021."},{"key":"378_CR17","unstructured":"Merck. Merck Statement on Ivermectin use During the COVID-19 Pandemic. https:\/\/www.merck.com\/news\/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic\/. Published February 4, 2021. Accessed November 22, 2021."},{"key":"378_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015017.pub2","author":"M Popp","year":"2021","unstructured":"Popp M, Stegemann M, Metzendorf M-I, et al. Ivermectin for preventing and treating COVID-19. Cochrane Collaboration. 2021. https:\/\/doi.org\/10.1002\/14651858.CD015017.pub2.","journal-title":"Cochrane Collaboration"},{"issue":"11","key":"378_CR19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jama.2011.322","volume":"305","author":"CH Hennekens","year":"2011","unstructured":"Hennekens CH, DeMets D. Statistical association and causation: contributions of different types of evidence. JAMA. 2011;305(11):1134\u20135. https:\/\/doi.org\/10.1001\/jama.2011.322.","journal-title":"JAMA"},{"key":"378_CR20","volume-title":"Epidemiology in Medicine","author":"CH Hennekens","year":"1987","unstructured":"Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown and Company, Lippincott, Wolters Kluwer; 1987."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-022-00378-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:23:15Z","timestamp":1648574595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-022-00378-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s43441-022-00378-0","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Molnar, Dr. Lau, Ms. Berges, Mr. Masa, Dr. Solano, Dr. Alter, Dr. Clayton, and Professors Shih and Maki have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}